The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange

Journal of Biotechnology
A S CoroadinhaM J T Carrondo

Abstract

Currently, retroviral vector producer cell lines must be established for the production of each gene vector. This is done by transfection of a packaging cell line with the gene of interest. In order to find a high-titer retroviral vector producer clone, exhaustive clone screening is necessary, as the random integration of the transgene gives rise to different expression levels. We established a virus producing packaging cell line, the 293 FLEX, in which the viral vector is flanked by two different FRT sites and a selection trap. Using Flp recombinase mediated cassette exchange; this vector can be replaced by another compatible retroviral vector. The first step was the tagging of 293 cells with a lacZ reporter gene, which allowed screening and choosing a high expressing chromosomal locus. After checking that, a single copy of the construct was integrated, cassette exchangeability was confirmed with a reporter targeting construct. Subsequently gag-pol and GaLV envelope genes were stably transfected. The lacZ transgene was replaced by a GFP transgene and the 293 FLEX producer cell line maintained the titer, thus validating the flexibility and efficacy of this producer cell line. The tagged retroviral producer cell clone should con...Continue Reading

References

Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·O Danos, R C Mulligan
Jun 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·R H HoessN Sternberg
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·K A Westerman, P Leboulch
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·D S OryR C Mulligan
Jan 13, 1998·Nature Genetics·A P Wolffe
Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
Sep 6, 2000·Cells, Tissues, Organs·H HauserD Wirth
May 3, 2003·Nature Reviews. Genetics·Clare E ThomasMark A Kay
Jun 20, 2003·Journal of Biotechnology·Marcio C BajgelmanBryan E Strauss

❮ Previous
Next ❯

Citations

Sep 19, 2009·Cell Biology and Toxicology·Roland SchuchtTobias May
Nov 13, 2008·Cytotechnology·James N WarnockMohamed Al-Rubeai
Nov 4, 2010·Human Gene Therapy·Manuel CarrondoHansjörg Hauser
Dec 17, 2009·BMC Biotechnology·Kristina NehlsenDagmar Wirth
Oct 2, 2007·Current Opinion in Biotechnology·Dagmar WirthHansjörg Hauser
Jun 10, 2009·The Journal of Gene Medicine·Marlene CarmoPedro Estilita Cruz
May 9, 2012·Biotechnology and Bioengineering·Fabiana FernandesPaula M Alves
Aug 6, 2009·Biotechnology and Bioengineering·A F RodriguesA S Coroadinha
Apr 26, 2016·Molecular Therapy. Methods & Clinical Development·Otto-Wilhelm MertenChiara Bovolenta
Oct 29, 2013·Journal of Biotechnology·João VidigalAna P Teixeira
Jul 14, 2010·MAbs·Feng LiAshraf Amanullah
May 3, 2013·PloS One·Mónica Díaz-CoránguezLorenza González-Mariscal
May 16, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·R SchuchtDagmar Wirth
Jan 22, 2018·Biotechnology Letters·Hugo R SoaresAna S Coroadinha
Mar 29, 2018·Scientific Reports·H A TomásA S Coroadinha
Dec 21, 2017·Scientific Reports·Quang Vinh PhanManfred Gossen
Oct 7, 2010·Expert Review of Vaccines·António RoldãoPaula M Alves
Feb 22, 2011·Journal of Biomolecular Screening·Roland SchuchtTobias May
Feb 13, 2021·Viruses·Christopher Perry, Andrea C M E Rayat

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.